دورية أكاديمية
Changes in life expectancy for cancer patients over time since diagnosis
| العنوان: | Changes in life expectancy for cancer patients over time since diagnosis |
|---|---|
| المؤلفون: | Botta L., Dal Maso L., Guzzinati S., Panato C., Gatta G., Trama A., Rugge M., Tagliabue G., Casella C., Caruso B., Michiara M., Ferretti S., Sensi F., Tumino R., Toffolutti F., Russo A. G., Caiazzo A. L., Mangone L., Mazzucco W., Iacovacci S., Ricci P., Gola G., Candela G., Sardo A. S., De Angelis R., Buzzoni C., Capocaccia R., AIRTUM Working Group |
| المساهمون: | Botta, L., Dal Maso, L., Guzzinati, S., Panato, C., Gatta, G., Trama, A., Rugge, M., Tagliabue, G., Casella, C., Caruso, B., Michiara, M., Ferretti, S., Sensi, F., Tumino, R., Toffolutti, F., Russo, A. G., Caiazzo, A. L., Mangone, L., Mazzucco, W., Iacovacci, S., Ricci, P., Gola, G., Candela, G., Sardo, A. S., De Angelis, R., Buzzoni, C., Capocaccia, R., AIRTUM Working, Group |
| سنة النشر: | 2019 |
| المجموعة: | Università degli Studi di Ferrara: CINECA IRIS |
| مصطلحات موضوعية: | Life expectancy, Population-based cancer registry, Relative survival, Cancer, Cancer survivors, Italy |
| الوصف: | The aims of this study were to provide life expectancy (LE) estimates of cancer patients at diagnosis and LE changes over time since diagnosis to describe the impact of cancer during patients' entire lives. Cancer patients' LE was calculated by standard period life table methodology using the relative survival of Italian patients diagnosed in population-based cancer registries in 1985–2011 with follow-up to 2013. Data were smoothed using a polynomial model and years of life lost (YLL) were calculated as the difference between patients' LE and that of the age- and sex-matched general population. The YLL at diagnosis was highest at the youngest age at diagnosis, steadily decreasing thereafter. For patients diagnosed at age 45 years, the YLL was above 20 for lung and ovarian cancers and below 6 for thyroid cancer in women and melanoma in men. LE progressively increased in patients surviving the first years, decreasing thereafter, to approach that of the general population. YLL in the long run mainly depends on attained age. Providing quantitative data is essential to better define clinical follow-up and plan health care resource allocation. These results help assess when the excess risk of death from tumour becomes negligible in cancer survivors. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | STAMPA |
| اللغة: | English |
| العلاقة: | info:eu-repo/semantics/altIdentifier/pmid/31467707; info:eu-repo/semantics/altIdentifier/wos/WOS:000497955100015; volume:20; firstpage:153; lastpage:159; numberofpages:7; journal:JOURNAL OF ADVANCED RESEARCH; http://hdl.handle.net/11392/2408656Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85070868417; https://www.sciencedirect.com/science/article/pii/S2090123219301353Test? |
| DOI: | 10.1016/j.jare.2019.07.002 |
| الإتاحة: | https://doi.org/10.1016/j.jare.2019.07.002Test http://hdl.handle.net/11392/2408656Test https://www.sciencedirect.com/science/article/pii/S2090123219301353Test? |
| حقوق: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.73B15214 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.jare.2019.07.002 |
|---|